연구동향 분석

The characterization of tumor-associated microbiota in patients with colorectal cancer = 대장암 환자의 종양 연관 장내미생물의 특성에 관한 연구

표대희 2022년

논문상세정보
인용/피인용
' The characterization of tumor-associated microbiota in patients with colorectal cancer = 대장암 환자의 종양 연관 장내미생물의 특성에 관한 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Colorectal cancer
  • Tumor microenvironment
  • Tumor sidedness
  • Tumor-associated microbiota
  • microbiome
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
298 0

0.0%

' The characterization of tumor-associated microbiota in patients with colorectal cancer = 대장암 환자의 종양 연관 장내미생물의 특성에 관한 연구' 의 참고문헌

  • Cancer and the microbiota
    Garrett WS 348 ( 6230 ) :80-6 [2015]
  • 9. Hamada T, Zhang X, Mima K, et al. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunology Research. 2018;6(11):canimm.0174.2018.
    [2018]
  • 7. Flemer B, Lynch DB, Brown JMR, et al. Tumour-associated and non-tumourassociated microbiota in colorectal cancer. Gut. 2017;66(4):633.
    [2017]
  • 6. Coleman OI, Haller D. Microbe–Mucus Interface in the Pathogenesis of Colorectal Cancer. Cancers. 2021;13(4):616.
  • 5. Bullman S, Pedamallu CS, Sicinska E, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):eaal5240.
    [2017]
  • 4. Borowsky J, Haruki K, Lau MC, et al. Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment. Clinical Cancer Research. 2021;27(10):2816-26.
  • 32. Becht E, de Reyniès A, Giraldo NA, et al. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy. Clin Cancer Res. 2016;22(16):4057-66.
    [2016]
  • 31. Rossi T, Vergara D, Fanini F, Maffia M, Bravaccini S, Pirini F. Microbiota-Derived Metabolites in Tumor Progression and Metastasis. International Journal of Molecular Sciences. 2020;21(16):5786.
    [2020]
  • 30. Mullins CS, Gock M, Krohn M, Linnebacher M. Human Colorectal Carcinoma Infiltrating B Lymphocytes Are Active Secretors of the Immunoglobulin Isotypes A, G, and M. Cancers. 2019;11(6):776.
    [2019]
  • 3. Fujisaka S, Avila-Pacheco J, Soto M, et al. Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites. Cell Reports. 2018;22(11):3072-86.
    [2018]
  • 29. Hanus M, Parada-Venegas D, Landskron G, et al. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Frontiers in Immunology. 2021;12:612826.
  • 28. Burns MB, Montassier E, Abrahante J, et al. Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment. PLOS Genetics. 2018;14(6):e1007376.
    [2018]
  • 27. Thomas AM, Jesus EC, Lopes A, et al. Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling. Front Cell Infect Microbiol. 2016;6:179.
    [2016]
  • 26. Phipps O, Quraishi MN, Dickson EA, et al. Differences in the On- and Off-Tumor Microbiota between Right- and Left-Sided Colorectal Cancer. Microorganisms. 2021;9(5):1108.
  • 25. Wilson AS, Koller KR, Ramaboli MC, et al. Diet and the Human Gut Microbiome: An International Review. Dig Dis Sci. 2020;65(3):723-40.
    [2020]
  • 24. Kim YS, Unno T, Kim BY, Park MS. Sex Differences in Gut Microbiota. World J Mens Health. 2020;38(1):48-60.
    [2020]
  • 23. Bibbò S, Ianiro G, Giorgio V, et al. The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci. 2016;20(22):4742-9.
    [2016]
  • 22. Wirth U, Garzetti D, Jochum LM, et al. Microbiome Analysis from Paired Mucosal and Fecal Samples of a Colorectal Cancer Biobank. Cancers. 2020;12(12):3702.
    [2020]
  • 21. Li Q, Hu W, Liu WX, et al. Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase. Gastroenterology. 2021;160(4):1179-93.e14.
  • 20. Chen D, Jin D, Huang S, et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456-67.
    [2020]
  • 2. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51.
    [2016]
  • 19. Buc E, Dubois D, Sauvanet P, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 2013;8(2):e56964.
    [2013]
  • 18. Hwang S, Lee CG, Jo M, et al. Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM/DSS mouse model. Int J Med Sci. 2020;17(2):145-52.
    [2020]
  • 17. Deng Q, Wang C, Yu K, et al. Streptococcus bovis Contributes to the Development of Colorectal Cancer via Recruiting CD11b⁺TLR-4⁺ Cells. Med Sci Monit. 2020;26:e921886.
    [2020]
  • 16. De Almeida CV, Lulli M, di Pilato V, et al. Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients. J Clin Med. 2019;8(3).
    [2019]
  • 15. Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer. PLOS ONE. 2015;10(3):e0119462.
    [2015]
  • 14. Sayed IM, Chakraborty A, El-Hafeez AAA, et al. The DNA Glycosylase NEIL2 Suppresses Fusobacterium-Infection-Induced Inflammation and DNA Damage in Colonic Epithelial Cells. Cells. 2020;9(9):1980.
    [2020]
  • 13. Nosho K, Sukawa Y, Adachi Y, et al. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World Journal of Gastroenterology. 2016;22(2):557-66.
    [2016]
  • 12. Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65(12):1973.
    [2016]
  • 11. Lee D-W, Han S-W, Kang J-K, et al. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Annals of Surgical Oncology. 2018;25(11):3389-95.
    [2018]
  • 10. Kong C, Yan X, Zhu Y, et al. Fusobacterium nucleatum promotes the development of colorectal cancer by activating a cytochrome P450/epoxyoctadecenoic acid axis via TLR4/Keap1/NRF2 signaling. Cancer Research. 2021 DOI: 10.1158/0008-5472.can13 21-0453 PMID - 34162680.canres.0453.2021.
  • 1. Youngblut ND, Reischer GH, Walters W, et al. Host diet and evolutionary history explain different aspects of gut microbiome diversity among vertebrate clades. Nature Communications. 2019;10(1):2200.
    [2019]